Skip to main content
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
1,545.00
+10.00 (0.65%)
Jun 27, 2025, 3:30 PM JST

Ono Pharmaceutical Revenue

In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B JPY, down -3.14%. Ono Pharmaceutical had revenue of 112.31B in the quarter ending March 31, 2025, a decrease of -0.41%.

Revenue
486.87B
Revenue Growth
-3.14%
P/S Ratio
1.52
Revenue / Employee
126.36M
Employees
3,853
Market Cap
741.77B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,222.12B
Takeda Pharmaceutical Company 4,581.55B
Daiichi Sankyo Company 1,886.26B
HOYA Corporation 866.03B
Terumo 1,036.17B
Otsuka Holdings 2,393.18B
Astellas Pharma 1,912.32B
Shionogi & 438.27B
Revenue Rankings

Ono Pharmaceutical News

More News